213 results on '"Perri, Patrizia"'
Search Results
2. Recent advances in the developmental origin of neuroblastoma: an overview
3. Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
4. Coated cationic lipid-nanoparticles entrapping miR-660 inhibit tumor growth in patient-derived xenografts lung cancer models
5. Quiescent hepatic stellate cells functionally contribute to the hepatic innate immune response via TLR3.
6. Antitumor activity of the investigational B7-H3 antibody-drug conjugate, vobramitamab duocarmazine, in preclinical models of neuroblastoma
7. Abstract 2981: Anti-tumor activity of vobramitamab duocarmazine (MGC018), an investigational duocarmycin-based anti-B7-H3 antibody-drug conjugate (ADC), in preclinical neuroblastoma models
8. Abstract 3407: The italian personalized medicine program PREME for high-risk neuroblastoma
9. Data from ALK-Dependent Control of Hypoxia-Inducible Factors Mediates Tumor Growth and Metastasis
10. Data from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
11. Supplementary Figure 1 from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
12. Supplementary Methods from Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
13. Supplementary Figure Legends from ALK-Dependent Control of Hypoxia-Inducible Factors Mediates Tumor Growth and Metastasis
14. Supplementary Figures 1-19 from ALK-Dependent Control of Hypoxia-Inducible Factors Mediates Tumor Growth and Metastasis
15. Therapeutic Targeting of ALK in Neuroblastoma: Experience of Italian Precision Medicine in Pediatric Oncology
16. Tumor vascular targeted liposomal-bortezomib minimizes side effects and increases therapeutic activity in human neuroblastoma
17. Nucleolin expression has prognostic value in neuroblastoma patients
18. Abstract 1276: Nucleolin has prognostic value in neuroblastoma patients
19. Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma
20. Genetic Predisposition to Familial Neuroblastoma : Identification of Two Novel Genomic Regions at 2p and 12p
21. MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT Pathway
22. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma
23. A Focus on Regulatory Networks Linking MicroRNAs, Transcription Factors and Target Genes in Neuroblastoma
24. Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors
25. Cotargeting of miR‐126‐3p and miR‐221‐3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signalling
26. The Olive Leaves Extract Has Anti-Tumor Effects against Neuroblastoma through Inhibition of Cell Proliferation and Induction of Apoptosis
27. Additional file 5 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
28. Additional file 3 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
29. Additional file 2 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
30. Additional file 4 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
31. Additional file 9 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
32. Additional file 7 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
33. Additional file 6 of Cell surface Nucleolin represents a novel cellular target for neuroblastoma therapy
34. Bone Marrow Environment in Metastatic Neuroblastoma
35. Identification of ALK as a major familial neuroblastoma predisposition gene
36. Concomitant DDX1 and MYCN gain in neuroblastoma
37. PHOX2B mutations and genetic predisposition to neuroblastoma
38. Potential Role of miRNAs in the Acquisition of Chemoresistance in Neuroblastoma
39. Metastatic progression in infants diagnosed with stage 4S neuroblastoma. A study of the Italian Neuroblastoma Registry
40. Weak linkage at 4p16 to predisposition for human neuroblastoma
41. Potential Onco-Suppressive Role of miR122 and miR144 in Uveal Melanoma through ADAM10 and C-Met Inhibition
42. Combined Replenishment of miR‐34a and let‐7b by Targeted Nanoparticles Inhibits Tumor Growth in Neuroblastoma Preclinical Models
43. Abstract A101: Nucleolin: A novel cell surface protein for neuroblastoma targeted therapy
44. A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A
45. Oligogenic inheritance in neuroblastoma
46. Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells
47. Linkage Analysis in Families with Recurrent Neuroblastoma
48. Overcoming Biological Barriers in Neuroblastoma Therapy: The Vascular Targeting Approach with Liposomal Drug Nanocarriers
49. Enhancement of Tumor Homing by Chemotherapy-Loaded Nanoparticles
50. Targeting Macrophages as a Potential Therapeutic Intervention: Impact on Inflammatory Diseases and Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.